Maryland Senate Bill 63 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 13 2016 - 25% progression, died in chamber
Action: 2016-03-16 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]

Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; specifying the manner in which a specified drug, product, or device may be provided to eligible patients; prohibiting a health occupations board from taking specified action against a health care provider's license on a specified basis; establishing that the Act does not create a specified cause of action; etc.

Investigational Drugs, Biological Products, and Devices - Right to Try Act

Sen. Bryan Simonaire [R]

Date	Chamber	Action
2016-03-16	Senate	Unfavorable Report by Finance; Withdrawn
2016-01-28	Senate	Hearing 1/28 at 1:00 p.m.
2016-01-13	Senate	First Reading Finance
2015-07-22	Senate	Pre-filed

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0063?ys=2016rs
Text	https://mgaleg.maryland.gov/2016RS/bills/sb/sb0063f.pdf
Supplement	https://mgaleg.maryland.gov/2016RS/fnotes/bil_0003/sb0063.pdf
Supplement	https://mgaleg.maryland.gov/2016RS/votes_comm/sb0063_fin.pdf